Holen Sie sich die Stockscreener-App
15.35
1.39%
0.21
Handel nachbörslich:
15.55
0.20
+1.30%
Schlusskurs vom Vortag:
$15.14
Offen:
$15.28
24-Stunden-Volumen:
1.16M
Relative Volume:
1.47
Marktkapitalisierung:
$1.62B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-150.70M
KGV:
-9.9032
EPS:
-1.55
Netto-Cashflow:
$-125.67M
1W Leistung:
-0.58%
1M Leistung:
+3.16%
6M Leistung:
+33.59%
1J Leistung:
-46.12%
1-Tages-Spanne:
$15.21
$16.03
1-Wochen-Bereich:
$14.85
$16.03
52-Wochen-Spanne:
$10.60
$38.12
Edgewise Therapeutics Inc Stock (EWTX) Company Profile
Firmenname
Edgewise Therapeutics Inc
Sektor
Branche
Telefon
720-262-7002
Adresse
1715 38TH ST, BOULDER
Vergleichen Sie EWTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EWTX
Edgewise Therapeutics Inc
|
15.35 | 1.59B | 0 | -150.70M | -125.67M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.15 | 105.19B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
450.68 | 60.24B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.86 | 61.82B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
798.94 | 49.09B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
351.09 | 37.52B | 4.56B | -176.77M | 225.30M | -1.7177 |
Edgewise Therapeutics Inc Stock (EWTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-25 | Eingeleitet | Goldman | Neutral |
| 2025-07-30 | Eingeleitet | Raymond James | Strong Buy |
| 2025-06-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-04-30 | Eingeleitet | Guggenheim | Buy |
| 2025-04-02 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-01-22 | Eingeleitet | Stifel | Hold |
| 2024-11-22 | Eingeleitet | Evercore ISI | Outperform |
| 2024-03-07 | Eingeleitet | Piper Sandler | Overweight |
| 2023-05-01 | Eingeleitet | Truist | Buy |
| 2022-08-25 | Herabstufung | Goldman | Neutral → Sell |
| 2022-04-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-01-28 | Eingeleitet | Goldman | Neutral |
Alle ansehen
Edgewise Therapeutics Inc Aktie (EWTX) Neueste Nachrichten
Edgewise Therapeutics (EWTX): Evaluating Valuation as New Long-Term Clinical Data Sparks Investor Interest - Yahoo Finance
How Investors Are Reacting To Edgewise Therapeutics (EWTX) Unveiling Long-Term Data for Sevasemten at WMS 2025 - Sahm
Edgewise Therapeutics presents muscular dystrophy research at Vienna conference - Traders Union
Tools to monitor Edgewise Therapeutics Inc. recovery probabilityWeekly Trend Report & Long-Term Growth Stock Strategies - newser.com
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules - Eastern Progress
Edgewise Therapeutics (EWTX): Reviewing Valuation After Recent Momentum Shifts - Sahm
Edgewise Therapeutics, Inc. $EWTX Shares Acquired by HighMark Wealth Management LLC - MarketBeat
Best data tools to analyze Edgewise Therapeutics Inc. stockTrade Entry Report & Smart Money Movement Tracker - newser.com
Will earnings trigger a reversal in Edgewise Therapeutics Inc.Weekly Trend Recap & Short-Term Swing Trade Alerts - newser.com
Edgewise Therapeutics reports inducement grants as permitted by Nasdaq listing rules - MarketScreener
247K Stock Options: Edgewise Grants Inducement Awards (15K RSUs) to 9 New Hires - Stock Titan
What drives Edgewise Therapeutics Inc stock priceInsider Trading Activity & Low Entry Cost Investments - earlytimes.in
Breakthrough Muscular Dystrophy Treatment: Edgewise's Sevasemten Shows Disease Stabilization in Key Trials - Stock Titan
Wall Street Analysts Think Edgewise Therapeutics (EWTX) Could Surge 182%: Read This Before Placing a Bet - MSN
Is Edgewise Therapeutics Inc a good long term investmentShort-Term Trading Alerts & Set Up Real-Time Alerts – It’s Free - earlytimes.in
What analysts say about Edgewise Therapeutics Inc stockGap Up/Gap Down Analysis & Capital Planning and Optimization - Early Times
Edgewise Therapeutics (NASDAQ:EWTX) Raised to "Hold" at The Goldman Sachs Group - MarketBeat
Edgewise Therapeutics (NASDAQ:EWTX) Trading Down 8.5%Here's Why - MarketBeat
The Goldman Sachs Group Begins Coverage on Edgewise Therapeutics (NASDAQ:EWTX) - MarketBeat
Goldman Sachs Initiates Coverage of Edgewise Therapeutics (EWTX) with Neutral Recommendation - Nasdaq
Goldman Sachs initiates Edgewise Therapeutics stock with Neutral rating By Investing.com - Investing.com Canada
Edgewise Therapeutics (NASDAQ:EWTX) Trading 8.5% HigherShould You Buy? - MarketBeat
Pattern recognition hints at Edgewise Therapeutics Inc. upsideWeekly Volume Report & Capital Protection Trading Alerts - newser.com
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives $40.55 Average Price Target from Analysts - MarketBeat
Edgewise Therapeutics (NASDAQ:EWTX) Trading Down 4.8%Should You Sell? - MarketBeat
Full technical analysis of Edgewise Therapeutics Inc. stockAnalyst Upgrade & Risk Adjusted Buy/Sell Alerts - newser.com
Will Edgewise Therapeutics Inc. continue its uptrendPortfolio Return Summary & High Conviction Investment Ideas - newser.com
Guidance Update: Can Edgewise Therapeutics Inc expand its profit marginsLayoff News & Daily Profit Focused Screening - خودرو بانک
Trade Recap: Is Edgewise Therapeutics Inc subject to activist investor interest2025 Earnings Impact & Accurate Technical Buy Alerts - خودرو بانک
Will Edgewise Therapeutics Inc. benefit from macro trendsQuarterly Risk Review & Safe Capital Growth Stock Tips - newser.com
Institutional scanner results for Edgewise Therapeutics Inc.2025 Retail Activity & Fast Exit Strategy with Risk Control - newser.com
What does recent volatility data suggest for Edgewise Therapeutics Inc.Market Weekly Review & AI Driven Price Predictions - newser.com
Analyzing recovery setups for Edgewise Therapeutics Inc. investorsJuly 2025 Trade Ideas & Real-Time Market Sentiment Alerts - newser.com
What indicators show strength in Edgewise Therapeutics Inc.July 2025 WrapUp & Weekly Setup with ROI Potential - newser.com
Predicting Edgewise Therapeutics Inc. trend using moving averages2025 Performance Recap & Weekly High Momentum Picks - newser.com
Aug Mood: Is Edgewise Therapeutics Inc. a cyclical or defensive stockJuly 2025 Macro Moves & Low Risk Growth Stock Ideas - خودرو بانک
Evaluating Edgewise Therapeutics Inc. with trendline analysisEarnings Overview Report & Precise Buy Zone Tips - newser.com
Goldman Sachs Group Inc. Has $8.07 Million Holdings in Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Should you wait for a breakout in Edgewise Therapeutics Inc.July 2025 Recap & Reliable Entry Point Trade Alerts - newser.com
Insider Buy: Can Edgewise Therapeutics Inc reach all time highs this yearMarket Growth Summary & Verified Swing Trading Watchlists - خودرو بانک
Risk Report: What analysts say about Edgewise Therapeutics Inc stockBear Alert & Verified Chart Pattern Signals - khodrobank.com
Weekly Trades: Whats the outlook for Edgewise Therapeutics Incs sector2025 Price Action Summary & Real-Time Buy Zone Alerts - خودرو بانک
Wall Street Recap: Will Edgewise Therapeutics Inc. benefit from current market trendsWeekly Stock Report & Free Community Supported Trade Ideas - khodrobank.com
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
Custom watchlist performance reports with Edgewise Therapeutics Inc.2025 Price Targets & Low Risk Growth Stock Ideas - newser.com
Finanzdaten der Edgewise Therapeutics Inc-Aktie (EWTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.05%
4.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):